Morningside Venture Investments Limited 13D/13G Filings for Apellis Pharmaceuticals, Inc. (APLS)

Morningside Venture Investments Limited 13D and 13G filings for Apellis Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-14
4:05 pm
Purchase
2021-12-3113GApellis Pharmaceuticals, Inc.
APLS
Morningside Venture Investments Limited12,806,342
13.200%
250,000increase
(+1.99%)
Filing
2021-02-16
4:17 pm
Purchase
2020-12-3113GApellis Pharmaceuticals, Inc.
APLS
Morningside Venture Investments Limited12,556,342
15.800%
540,540increase
(+4.50%)
Filing